MétaCan
Menu
Back to cohort
Record W2060277785 · doi:10.1158/1078-0432.ovca13-a20

Abstract A20: Integrating high-throughput technologies for the identification and validation of ovarian cancer biomarkers

2013· article· en· W2060277785 on OpenAlexaffabout
Felix Leung, Apostolos Dimitromanolakis, Eleftherios P. Diamandis, Vathany Kulasingam

Bibliographic record

VenueClinical Cancer Research · 2013
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBiological Research and Disease Studies
Canadian institutionsUniversity Health NetworkMount Sinai HospitalUniversity of Toronto
Fundersnot available
KeywordsOvarian cancerCancerMedicineBiomarker discoveryMalignancyIdentification (biology)BiomarkerProteomicsBioinformaticsComputational biologyOncologyBiologyInternal medicineGene

Abstract

fetched live from OpenAlex

Abstract Background: Ovarian cancer (OvCa) is the most lethal gynecological malignancy in Canada. The 5-year survival rate for OvCa diagnosed at stage I or II is 80-95%, whereas diagnosis at more advanced stages is associated with survival rates of 10-30%. Proteomic analyses of OvCa fluid and conditioned media from cultured human OvCa cell lines has allowed for the identification of protein candidates as highly promising novel OvCa biomarkers. These candidates need further investigation to decipher their true potential to be reliable biomarkers for early stage OvCa. Hypothesis & Objectives: We hypothesize that through complementing our proteomic data with transcriptomics and bioinformatics, we will be able to identify and validate novel OvCa serum biomarkers. Specifically, we will establish a filtering algorithm using criteria based on biological soundness in order to prioritize the discovery candidates according to their potential to be novel OvCa biomarkers. Filtered candidates will then be assessed in the serum of healthy women and women with OvCa through quantitative assays to determine how effectively they distinguish between the cohorts. Methods: Filtering criteria with established scoring systems will be applied to the discovery candidates. As a proof-of-principle, the filtering algorithm will also be applied to known serum tumor markers. Filtered candidates will then be screened for their clinical relevance in serum through commercially-available enzyme-linked immunosorbent assays (ELISAs) and in-house developed mass spectrometry-based quantitative assays. Results: Sixteen high-priority candidates and known tumor markers were identified through filters based on cellular localization, differential mRNA expression, and computational prediction for secretion status. We have so far verified the sixteen candidates for their concentrations in a small cohort of healthy control and OvCa sera; kallikrein 6 (KLK6), folate receptor alpha precursor (FOLR1), granulin (GRN), basal cell adhesion molecule (BCAM), and Dickkopf-related protein 3 (Dkk-3) have displayed promising results. KLK6 and BCAM have retained their discriminatory power in subsequent independent validation cohorts and will be investigated further. Conclusions: In silico analyses can help highlight protein candidates from discovery-phase experiments with strong potential to be biomarkers for early OvCa diagnosis. However, proper verification and independent validation using gold-standard techniques is necessary to truly assess the ability of candidates to be clinically relevant biomarkers. Citation Format: Felix Leung, Apostolos Dimitromanolakis, Eleftherios P. Diamandis, Vathany Kulasingam. Integrating high-throughput technologies for the identification and validation of ovarian cancer biomarkers. [abstract]. In: Proceedings of the AACR Special Conference on Advances in Ovarian Cancer Research: From Concept to Clinic; Sep 18-21, 2013; Miami, FL. Philadelphia (PA): AACR; Clin Cancer Res 2013;19(19 Suppl):Abstract nr A20.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.005
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.508
Threshold uncertainty score0.626

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.005
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.159
GPT teacher head0.500
Teacher spread0.342 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2013
Admission routes2
Has abstractyes

Explore more

Same venueClinical Cancer ResearchSame topicBiological Research and Disease StudiesFrench-language works237,207